{"schema_version":"secwatch.filing_event.v1","accession":"0001683168-24-005919","form_type":"8-K","ticker":"ACTU","cik":"0001652935","company_name":"ACTUATE THERAPEUTICS, INC.","filed_at":"2024-08-19T23:59:59+00:00","discovered_at":"2026-05-14T18:03:13.973964+00:00","generated_at":"2026-05-31T08:41:12.393602+00:00","sec_items":["4.01","9.01"],"event_type":"regulatory","sentiment":"negative","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Actuate Therapeutics replaces auditor after KMJ joins Crowe; prior reports cite going concern and material weakness","bullets":["KMJ Corbin & Company LLP resigned as auditor on Aug 19, 2024; Crowe LLP appointed same day.","KMJ audit reports for FY2023 and FY2022 included a going-concern explanatory paragraph about substantial doubt.","Company reported a material weakness in internal control over financial reporting due to inadequate review of clinical trial expense accruals.","No disagreements between Company and KMJ on accounting principles or auditing scope.","KMJ's professional staff joined Crowe LLP on May 20, 2024; change is related to that merger."],"urls":{"canonical":"https://secwatch.observer/filing/0001683168-24-005919","json":"https://secwatch.observer/filing/0001683168-24-005919.json","markdown":"https://secwatch.observer/filing/0001683168-24-005919.md","text":"https://secwatch.observer/filing/0001683168-24-005919.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1652935/000168316824005919/0001683168-24-005919-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1652935/000168316824005919/actuate_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-31T08:41:12.393602+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}